262 related articles for article (PubMed ID: 10509642)
21. Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: I. Experimental characterizations.
Tong S; Yuan F
Microvasc Res; 2008 Jan; 75(1):10-5. PubMed ID: 17706726
[TBL] [Abstract][Full Text] [Related]
22. Rapid ocular angiogenic control via naked DNA delivery to cornea.
Stechschulte SU; Joussen AM; von Recum HA; Poulaki V; Moromizato Y; Yuan J; D'Amato RJ; Kuo C; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1975-9. PubMed ID: 11481260
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
24. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
25. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.
Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4356-64. PubMed ID: 17003426
[TBL] [Abstract][Full Text] [Related]
26. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization.
BenEzra D; Griffin BW; Maftzir G; Sharif NA; Clark AF
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1954-62. PubMed ID: 9331259
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of corneal neovascularization by rapamycin.
Kwon YS; Kim JC
Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
[TBL] [Abstract][Full Text] [Related]
28. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment.
Lin HC; Chang JH; Jain S; Gabison EE; Kure T; Kato T; Fukai N; Azar DT
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2517-24. PubMed ID: 11581192
[TBL] [Abstract][Full Text] [Related]
29. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.
Klotz O; Park JK; Pleyer U; Hartmann C; Baatz H
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):88-93. PubMed ID: 10664059
[TBL] [Abstract][Full Text] [Related]
31. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
32. Drug modification of angiogenesis in a rat cornea model.
Schwartz S; George J; Ben-Shoshan J; Luboshits G; Avni I; Levkovitch-Verbin H; Ziv H; Rosner M; Barak A
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):250-4. PubMed ID: 18172099
[TBL] [Abstract][Full Text] [Related]
33. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
[TBL] [Abstract][Full Text] [Related]
34. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells.
Ferrara N; Clapp C; Weiner R
Endocrinology; 1991 Aug; 129(2):896-900. PubMed ID: 1855480
[TBL] [Abstract][Full Text] [Related]
35. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas.
Kojima T; Chung TY; Chang JH; Sayegh R; Casanova FH; Azar DT
Cornea; 2007 Jun; 26(5):569-78. PubMed ID: 17525654
[TBL] [Abstract][Full Text] [Related]
36. Basic fibroblast growth factor stimulates epithelial cell growth and epithelial wound healing in canine corneas.
Hu C; Ding Y; Chen J; Liu D; Zhang Y; Ding M; Wang G
Vet Ophthalmol; 2009; 12(3):170-5. PubMed ID: 19392876
[TBL] [Abstract][Full Text] [Related]
37. A novel vector system for gene transfer into the cornea using a partially dried plasmid expressing 18 basic fibroblast growth factor-synthetic amphiphile INTeraction-18 (SAINT-18) complex.
Kuo CN; Yang LC; Yang CT; Chen MF; Lai CH; Chen YH; Chen CH; Chen CH; Wu PC; Kou HK; Tsai JC; Hung CH
Curr Eye Res; 2008 Oct; 33(10):839-48. PubMed ID: 18853317
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory corneal neovascularization: etiopathogenesis.
Clements JL; Dana R
Semin Ophthalmol; 2011; 26(4-5):235-45. PubMed ID: 21958169
[TBL] [Abstract][Full Text] [Related]
39. The mouse cornea micropocket angiogenesis assay.
Rogers MS; Birsner AE; D'Amato RJ
Nat Protoc; 2007; 2(10):2545-50. PubMed ID: 17947997
[TBL] [Abstract][Full Text] [Related]
40. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
